During the past decade, Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)" #1 collaborator was "TC Erciyes University" with 2 trials as a collaborator, "Anapharm Bioanalytics" with 1 trials as a collaborator, "Kocak Farma" with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Monitor CRO" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)" are "Bioavailability" (1 trials), "Bioequivalence" (1 trials), "COVID-19 Vaccine" (1 trials), "Covid19" (1 trials) and "Healthy Subjects" (1 trials). Many other conditions were trialed in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)" in a lesser frequency.

Most popular intervention types in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arcoxia® 120 mg etoricoxib film-coated tablets" (1 trials), "ERUCOV-VAC" (1 trials), "EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule" (1 trials), "Exib 120 mg etoricoxib film-coated tablets" (1 trials) and "Placebo Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP)". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".